These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins. Pedersen-Bjergaard J; Petersen HD; Thomsen M; Wiik A; Wolff-Jensen J Scand J Haematol; 1978 Sep; 21(3):256-64. PubMed ID: 309624 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin types and features of multiple myeloma in northern Nigeria. Onyemelukwe GC; Kulkarni AG East Afr Med J; 1988 Jan; 65(1):33-8. PubMed ID: 3416793 [No Abstract] [Full Text] [Related]
8. Unusual cases of myelomatosis. Videbaek A Br Med J; 1971 May; 2(5757):326. PubMed ID: 4996472 [No Abstract] [Full Text] [Related]
9. An unusual case of myeloma. Smith J; Lieberman PH Clin Bull; 1974; 4(4):162-3. PubMed ID: 4462975 [No Abstract] [Full Text] [Related]
10. Thrombocythaemia and multiple myeloma. A report on two cases. Selroos O; van Assendelft A Acta Med Scand; 1977; 201(3):243-7. PubMed ID: 557871 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan. Meytes D; Katz DR Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846 [No Abstract] [Full Text] [Related]
12. [IgM myeloma]. Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914 [No Abstract] [Full Text] [Related]
15. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)]. Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836 [TBL] [Abstract][Full Text] [Related]
16. [Cutaneous plasmacytomas following treatment of IgA kappa multiple myeloma]. Ortín X; Llorente A; Martínez S; Ugarriza A Med Clin (Barc); 2004 Oct; 123(15):597-8. PubMed ID: 15535948 [No Abstract] [Full Text] [Related]
17. [Immunoglobulin E in patients with chronic lymphocytic leukaemia, multiple myeloma and morbus Waldenström (author's transl)]. Schwarz S; Gabl F; Pastner D; Huber H; Braunsteiner H Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):196-207. PubMed ID: 4283033 [No Abstract] [Full Text] [Related]
18. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma). Wiedermann D; Widermann B; Cídl K; Scudla V Neoplasma; 1979; 26(3):315-24. PubMed ID: 119165 [No Abstract] [Full Text] [Related]
19. The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma. Waller M; Moon JH; Irby R; Toone EC Clin Exp Immunol; 1971 Jan; 8(1):91-100. PubMed ID: 4993198 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients. Matzner Y; Benbassat J; Polliack A Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296 [No Abstract] [Full Text] [Related] [Next] [New Search]